Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese mice

Dipeptidyl peptidase IV (DPP-IV) inhibitors improve glycemic control by prolonging the action of glucagon-like peptide-1 (GLP-1). In contrast to GLP-1 analogues, DPP-IV inhibitors are weight-neutral. DPP-IV cleavage of PYY and NPY gives rise to PYY(3-36) and NPY(3-36) which exert potent anorectic ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Henrik H., Grønlund, Rikke V., Baader-Pagler, Tamara, Haebel, Peter, Tammen, Harald, Larsen, Leif Kongskov, Jelsing, Jacob, Vrang, Niels, Klein, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044192/
https://www.ncbi.nlm.nih.gov/pubmed/33850212
http://dx.doi.org/10.1038/s41598-021-87539-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044192/
https://www.ncbi.nlm.nih.gov/pubmed/33850212
http://dx.doi.org/10.1038/s41598-021-87539-7

Ejemplares similares